This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Camussone, C.
Right arrow Articles by Marcipar, I. S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Camussone, C.
Right arrow Articles by Marcipar, I. S.

 Previous Article  |  Next Article 

Clinical and Vaccine Immunology, June 2009, p. 899-905, Vol. 16, No. 6
1071-412X/09/$08.00+0     doi:10.1128/CVI.00005-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Comparison of Recombinant Trypanosoma cruzi Peptide Mixtures versus Multiepitope Chimeric Proteins as Sensitizing Antigens for Immunodiagnosis{triangledown}

Cecilia Camussone,1 Verónica Gonzalez,1 María S. Belluzo,2 Nazarena Pujato,1 María E. Ribone,2 Claudia M. Lagier,2 and Iván S. Marcipar1*

Laboratorio de Tecnología Biológica, Universidad Nacional del Litoral, Santa Fe, Argentina,1 Departamento de Química Analítica, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Rosario, Argentina2

Received 12 December 2008/ Returned for modification 30 January 2009/ Accepted 23 March 2009

The aim of this work was to determine the best strategy to display antigens (Ags) on immunochemical devices to improve test selectivity and sensitivity. We comparatively evaluated five Trypanosoma cruzi antigenic recombinant peptides, chose the three more sensitive ones, built up chimeras bearing these selected Ags, and systematically compared by enzyme-linked immunosorbent assay the performance of the assortments of those peptides with that of the multiepitope constructions bearing all those peptides lineally fused. The better-performing Ags that were compared included peptides homologous to the previously described T. cruzi flagellar repetitive Ag (here named RP1), shed acute-phase Ag (RP2), B13 (RP5), and the chimeric recombinant proteins CP1 and CP2, bearing repetitions of RP1-RP2 and RP1-RP2-RP5, respectively. The diagnostic performances of these Ags were assessed for discrimination efficiency by the formula +OD/cutoff value (where +OD is the mean optical density value of the positive serum samples tested), in comparison with each other either alone, in mixtures, or as peptide-fused chimeras and with total parasite homogenate (TPH). The discrimination efficiency values obtained for CP1 and CP2 were 25% and 52% higher, respectively, than those of their individual-Ag mixtures. CP2 was the only Ag that showed enhanced discrimination efficiency between Chagas' disease-positive and -negative samples, compared with TPH. This study highlights the convenience of performing immunochemical assays using hybrid, single-molecule, chimeric Ags instead of peptide mixtures. CP2 preliminary tests rendered 98.6% sensitivity when evaluated with a 141-Chagas' disease-positive serum sample panel and 99.4% specificity when assessed with a 164-Chagas' disease-negative serum sample panel containing 15 samples from individuals infected with Leishmania spp.


* Corresponding author. Present address: Ciudad Universitaria, Paraje El pozo, CC 242 (3000) Santa Fe, Argentina. Phone: 54 342-4575206, ext. 125. Fax: 54 342-4575206, ext. 118. E-mail: imarcipr{at}fbcb.unl.edu.ar

{triangledown} Published ahead of print on 1 April 2009.


Clinical and Vaccine Immunology, June 2009, p. 899-905, Vol. 16, No. 6
1071-412X/09/$08.00+0     doi:10.1128/CVI.00005-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.